Senior Manager, Global Protective Services and Intelligence

Responsibilities

• Lead and mature the enterprise Security Intelligence Program, including strategic intelligence, threat monitoring, and risk analysis.
• Develop program vision, operating models, governance, and performance metrics aligned to corporate risk priorities.
• Identify and track global threats such as geopolitical instability, terrorism, crime, and insider risk.
• Produce timely intelligence products including risk assessments, threat briefs, and travel risk guidance.
• Provide intelligence support for crisis management, emergency response, and business continuity efforts.
• Brief senior executives and cross-functional partners with actionable mitigation strategies.
• Manage relationships with external intelligence providers, law enforcement, and government partners.
• Mentor and develop Global Security Operations Center analysts and contractors.

Requirements

• Bachelor's degree in security studies, international relations, political science, intelligence, criminology, or a related field.
• 8+ years of experience in intelligence, security risk analysis, or threat assessment.
• Demonstrated experience leading or building intelligence programs in a corporate, government, or military environment.
• Strong analytical skills with the ability to translate complex information into clear guidance.
• Proven ability to brief senior executives and influence decision-making.
• Excellent written and verbal communication skills.

Preferred Qualifications

• Experience within the biotechnology sector.
• Experience supporting global operations, international travel risk, or crisis management programs.
• Familiarity with intelligence tools, threat monitoring platforms, and analytic frameworks.
• Prior experience in highly regulated or high-risk industries such as life sciences or critical infrastructure.

About the Company

BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions. Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered a portfolio of therapies since our founding in 1997.